DISCHARGE SUMMARY - Region 1 Medical Center, Dagupan City

Patient Information

Admission Details

• Date Admitted: July 12, 2024
• Attending Physician: Dr. Gazmin
• Date Discharge: (blank - not yet filled)

Diagnoses

• Admitting Diagnosis: Nosocomial Pneumonia, r/o MET (metastasis), Anemia Multifactorial, IHD (Ischemic Heart Disease)
• Final Diagnosis: (blank)

Chief Complaint

Brief Clinical History / Pertinent PE

Laboratory Findings Ordered

Course in the Ward

• Admit (for further management)

Date Accomplished

Note: The Disposition section (home medications, special instructions, follow-up) and Final Diagnosis fields appear blank, suggesting this form was either incomplete at the time of imaging or the patient was still admitted.

Management Plan

1. ACUTE DECOMPENSATED HEART FAILURE (ADHF)

A. Initial Stabilization & Monitoring

• Admit to ward (already done per document)
• Continuous SpO2, ECG monitoring, telemetry
• Daily weights, strict fluid balance (input/output charting)
• BMP/electrolytes daily (Na, K, Cl, HCO3, BUN, Creatinine) - watch for hypokalemia and worsening renal function
• BNP or NT-proBNP for severity assessment

B. Decongestion - the cornerstone

• Bolus vs. continuous infusion: Both are acceptable per the DOSE trial - continuous infusion showed similar outcomes to intermittent bolus, but high-dose furosemide achieved better net fluid loss at 72 hours with better dyspnea relief - Braunwald's Heart Disease, 15e, p. 114
• Monitor creatinine during aggressive diuresis (high-dose raises creatinine risk ~23%)
• Add spironolactone 25-50 mg if no contraindication (potassium-sparing, reduces neurohormonal activation)

C. Vasodilators (for pulmonary congestion)

• IV nitroglycerin (0.5-1 mcg/kg/min, titrate up) - rapid relief of pulmonary congestion, reduces preload and afterload. Especially useful if SBP >90 mmHg
• Hold or reduce if SBP drops below 90 mmHg
• Avoid in patients with right ventricular failure or hypotension

D. Neurohormonal Therapy (ongoing HF management)

• ACE inhibitor or ARB (e.g., Enalapril, Lisinopril) - reduce afterload and mortality
• Beta-blocker (e.g., Carvedilol, Bisoprolol) - if not decompensated and heart rate is elevated. Do NOT start or uptidate during active decompensation
• MRA (Mineralocorticoid receptor antagonist) - Spironolactone/Eplerenone if EF <35% and no hyperkalemia
• SGLT2 inhibitor (Empagliflozin/Dapagliflozin) - if tolerated, improves outcomes in HFrEF and HFpEF; also has diuretic-sparing properties

E. Oxygen Therapy

• Target SpO2 >94%
• Non-invasive positive pressure ventilation (CPAP or BiPAP) if respiratory distress persists despite O2 and diuresis - reduces need for intubation in pulmonary edema

F. Fluid/Sodium Restriction

• Fluid restriction: 1.5-2 L/day
• Sodium restriction: <2 g/day (120 mmol/day)

2. NOSOCOMIAL PNEUMONIA

Empiric Antibiotic Regimen

• Piperacillin-tazobactam 4.5 g IV q6h (covers Gram-negatives including Pseudomonas + anaerobes), OR
• Cefepime 2 g IV q8h + Metronidazole

• Cefepime 2 g IV q8h OR Meropenem 1 g IV q8h
• PLUS Vancomycin 15 mg/kg IV q12h (for MRSA coverage) OR Linezolid 600 mg IV q12h
• Consider anti-pseudomonal coverage with Levofloxacin 750 mg IV q24h

At age 82, renally dose ALL antibiotics based on CrCl (BUN/Cr already ordered on the labs).

Duration

• 7-8 days for nosocomial pneumonia (clinical response-guided)
• Follow sputum cultures and de-escalate to narrower coverage based on sensitivities

3. ANEMIA (MULTIFACTORIAL)

• Blood typing already ordered (BT noted in labs) - transfuse if symptomatic anemia or Hgb <7-8 g/dL (threshold of 8 in active cardiac disease/IHD)
• Packed Red Blood Cells (pRBCs) - transfuse cautiously in ADHF (small volumes, 1 unit at a time) to avoid worsening fluid overload
• Check: Iron studies, B12, folate, reticulocyte count to identify reversible causes
• If iron-deficient: IV Ferric carboxymaltose (preferred in HF - the AFFIRM-AHF trial showed reduced HF hospitalizations with IV iron in iron-deficient HF patients)
• Erythropoiesis-stimulating agents (EPO) if CKD-related anemia with Hgb <10 g/dL

4. ISCHEMIC HEART DISEASE (IHD)

• Aspirin 80 mg once daily (secondary prevention)
• Statin (e.g., Atorvastatin 40-80 mg) - pleiotropic benefits, continue or initiate
• Antianginal: Nitrates PRN (also helps with HF volume management)
• Beta-blocker: Once decompensation resolves
• Avoid NSAIDs - worsen fluid retention and renal function
• Consider further workup if ACS is suspected (troponin, serial ECGs)

5. GENERAL SUPPORTIVE CARE (Geriatric Considerations - 82F)

Summary of Priority Medications

Source references: Braunwald's Heart Disease 15e (pp. 114-182, Management of Acute Heart Failure); Rosen's Emergency Medicine 9e (Pneumonia Chapter, Antimicrobial Treatment Table)